Woundcare Product Launch

Advanced Medical Solutions Grp PLC
13 November 2007


For Immediate Release                                           13 November 2007

                      Advanced Medical Solutions Group plc
                             ('AMS' or 'the Group')


             UK launch of ActivHeal(R) AquaFiber(R) wound dressing
                       offers further savings for the NHS


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, today announces the UK launch of ActivHeal(R)
AquaFiber(R), a new advanced woundcare dressing that can deliver significant
cost and care benefits to the NHS.  The product will be unveiled today at the
Wounds UK 2007 Woundcare Conference in Harrogate, North Yorkshire.


ActivHeal(R) AquaFiber(R) is a soft, conformable and highly absorbent dressing.
In contact with wound exudate, the product forms a soft, clear gel providing an
ideal moist wound environment that supports the wound healing process. Indicated
for moderate to heavily exuding chronic and acute wounds, ActivHeal(R) AquaFiber
(R) also controls minor bleeding in superficial wounds.


The ActivHeal(R) range of products is designed and manufactured by AMS to
combine cost savings with technological innovation with the objective of
offering the NHS a cost-effective alternative to branded woundcare products.


ActivHeal(R) AquaFiber(R) competes in a segment of the advanced woundcare market
on which it is estimated that the NHS currently spends £15 million each year.
The ActivHeal(R) AquaFiber(R) dressing has been listed in the Drug Tariff and is
available for prescribing by NHS Trusts at an average price 30% lower than the
equivalent branded dressing, thus offering a significant immediate saving on NHS
woundcare budgets.


In a poster presented at the Harrogate conference, ActivHeal(R) AquaFibre(R) was
shown to be equivalent or better to a significantly more expensive leading brand
on all five performance characteristics tested including absorbency, speed of
absorbency, dry strength, wet strength and lateral wicking - all key attributes
of a moist wound healing dressing.


Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS,
stated:


'The addition of the new ActivHeal(R) AquaFiber(R) product to our ActivHeal(R)
range is another major step in providing advanced woundcare products to the NHS
that allow hospital and Primary Care Trusts to achieve substantial savings
without compromising patient care.'


For further information, please contact:


Advanced Medical Solutions Group plc

Don Evans, Chief Executive Officer                    Tel:  [phone]

Mary Tavener, Finance Director

www.admedsol.com

Buchanan Communications

Mark Court, Mary-Jane Johnson                         Tel: [phone]


Landsbanki Securities (UK) Ltd                        Tel: [phone]

Shaun Dobson / Xavier de Mol

Notes to Editors:



Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.


Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the
design, development and manufacture of innovative and technologically advanced
products for woundcare and other medical applications.


In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move a product from design and development through to production and delivery
ready for distribution into customer markets.


The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing topical wounds sold direct to hospitals or through
distributors.


AMS's technology and products currently serve the majority of the key global
markets and strategic partners.



                      This information is provided by RNS
            The company news service from the London Stock Exchange